Arthroscopy Market (2026 - 2033)

Arthroscopy Market Summary

The global arthroscopy market size was valued at USD 6.6 billion in 2025 and is projected to grow from USD 6.8 billion in 2026 to USD 8.5 billion by 2033, growing at a CAGR of 3.4% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 45.0% in 2025. The rising geriatric population is a key driver, as this age group is more prone to injuries requiring arthroscopic procedures. According to a March 2025 report in The Journal of Arthroscopic & Related Surgery, a large population-based study (over 300,000 patients aged >50 years) found that knee arthroscopy is frequently performed in older patients.

Sportspersons and athletes frequently suffer from sports-related injuries such as torn ligaments, meniscus tears, and cartilage tears; arthroscopy effectively treats them accurately and allows athletes to return to their sports quickly. Meniscus tear is the most common sports injury. One of the most common arthroscopic procedures is meniscus arthroscopy. A soft, C-shaped piece of cartilage called the meniscus acts as a cushion between the shinbone and the thighbone. Many basic actions, such as walking and stair climbing, depend on the proper function of the meniscus.

Osteoarthritis, a degenerative condition affecting one or more joints, affects approximately 30 million Americans. Around a million people have rheumatoid arthritis (RA), and around 750,000 of the over two million arthroscopic procedures in the U.S. each year include knee surgery.

Visualization systems are used to identify the injury at the joint site. The images can be displayed in 3D format with technological innovations at the forefront. Furthermore, the rise in the use of fluid management systems to optimize the visualization process will spur demand.

Market Dynamics

The market is driven by the increasing prevalence of musculoskeletal disorders, rising sports-related injuries, and the growing aging population. The demand for minimally invasive procedures is increasing due to benefits such as greater surgical precision, faster recovery, and shorter hospital stays. In addition, technological advancements in arthroscopic imaging and surgical instruments are further supporting market growth. However, the market is restrained by the high cost of arthroscopic equipment and procedures.

Analyst Perspective

The market is growing due to the increasing prevalence of joint disorders, sports injuries, and age-related musculoskeletal conditions. Arthroscopy is widely preferred because it is a minimally invasive procedure that enables faster recovery, reduced pain, and shorter hospital stays compared to traditional surgical methods. The growing number of knee, shoulder, and hip procedures, along with rising demand for advanced orthopedic treatments, is supporting market growth. In addition, technological advancements in arthroscopic instruments, visualization systems, and robotic-assisted surgery are improving surgical accuracy and patient outcomes.

Application Insights

The knee segment led the market, accounting for over 40.0% of revenue in 2025. This large share is attributed to the growing geriatric population and increasing incidence rate of injuries such as ligament tears, meniscal damage, and osteoarthritis. According to the Panorama Orthopedic & Spine report, ACL (anterior cruciate ligament) injuries represent a major contributor to knee arthroscopy demand, with approximately 400,000 ACL injuries occurring annually in the U.S. The high burden of ACL injuries significantly contributes to procedural volumes, as arthroscopy remains the preferred surgical approach for ligament reconstruction and soft tissue repair due to its minimally invasive nature.

The elbow segment is expected to witness the fastest CAGR during the forecast period, owing to the increasing number of Rheumatoid arthritis cases in developed economies such as the U.S. and other developing economies such as India and China. According to the Liv Hospital report, 1.3 million Americans are affected by Rheumatoid arthritis. Furthermore, the growing clinical preference for minimally invasive techniques, coupled with advancements in small-joint arthroscopic instruments specifically designed for elbow procedures, is expanding the applicability of arthroscopy for complex inflammatory joint conditions. Increasing awareness of early intervention in rheumatoid arthritis, along with improved access to orthopedic care in developing regions, is further expected to accelerate procedure volumes.

Product Insights

The market is segmented into visualization systems, ablation systems, powered shaver systems, arthroscopes, fluid management systems, arthroscopy implants, accessories, and disposables. The arthroscope implants segment dominated the market in terms of revenue, with over 45.0% share in 2025. Arthroscopic implants are used in arthroscopy surgeries to reconstruct ruptured joints. These implants are very well-designed and do not require any additional bending. Their increasing adoption is driven by the growing preference for minimally invasive surgeries, which offer benefits such as reduced blood loss, faster recovery, and lower risk of infection compared to open surgical procedures.

The visualization system segment is expected to grow at the fastest CAGR over the forecast period. This is attributed to increased surgeries, as visualization systems are used to assess injury extent. Hence, irrespective of the type of surgery, visualization systems are required, which drives the market for visualization systems. For instance, Zimmer Biomet’s ZEOS Arthroscopy Tower provides a 4K HDR visualization system with enhanced color and contrast, as well as real-time image processing, specifically designed for arthroscopic and endoscopic surgeries.

Regional Insights

North America dominated the market, accounting for over 45.0% in 2025. The U.S. dominated the region in 2025 owing to advanced healthcare infrastructure, rising healthcare expenditure, and the presence of key players. The market is further supported by a high volume of orthopedic procedures and widespread adoption of minimally invasive surgical techniques. The presence of skilled orthopedic surgeons, continuous technological advancements in arthroscopy equipment, and strong investments in healthcare innovation further support market growth across North America.

Asia Pacific Arthroscopy Market Trends

The arthroscopy market in the Asia Pacific is expected to grow at the fastest CAGR over the forecast period, driven by an aging population in Japan, China, and India. According to China's 2025 population survey released in May 2026, the population aged 60 years and above reached 321.2 million, accounting for 22.9% of the total population, highlighting the country's accelerating demographic aging trend. This demographic shift is expected to boost demand for arthroscopic procedures, as older adults are more susceptible to age-related musculoskeletal disorders such as osteoarthritis, degenerative joint diseases, cartilage deterioration, and meniscal injuries. 

Key Arthroscopy Company Insights

The key players in the market are undertaking strategies such as new product launches, mergers, collaborations, partnerships, and acquisitions to improve their market position.

Key Arthroscopy Companies

The following key companies have been profiled for this study on the arthroscopy market.

• CONMED Corporation

• Zimmer Biomet

• Henke Sass Wolf GmbH

• Johnson & Johnson

• KARL STORZ SE & Co. KG

• Arthrex, Inc.

• Richard Wolf GmbH

• Smith + Nephew

• Medtronic

• Stryker

Recent Developments

• In December 2025, the Articulator Arthroscopic Bur was designed for arthroscopic procedures and received FDA 510(k) clearance as an arthroscopic surgical instrument.

• In March 2023, Zimmer Biomet announced plans to unveil ZBEdge, an integrated software of digital and robotic technologies to improve efficiency and patient outcomes.

• In March 2023, Smith + Nephew unveiled “precise in motion” in the arthroscopy sector, which uses AI technology to personalize surgery, advance efficiency, and optimize performance.

• In January 2023, Arthrex, Inc. received FDA clearance for its product Tightrope, the only device cleared for pediatric ACL surgery. Such developments are likely to drive market growth.

Arthroscopy Market Report Scope

Global Arthroscopy Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global arthroscopy market report based on product, application, and region:

• Product Outlook (Revenue in USD Billion, 2021 - 2033)

  • Powered Shaver Systems

  • Visualization Systems

  • Fluid Management Systems

  • Ablation Systems

  • Arthroscopes

  • Arthroscope Implants

  • Accessories And Disposables

• Application Outlook (Revenue in USD Billion, 2021 - 2033)

  • Hip

  • Knee

  • Shoulder

  • Foot & ankle

  • Hand & wrist

  • Elbow

  • Sports injuries

• Region Outlook (Revenue in USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait